Ocugen, Bharat Biotech COVID vaccine shows better safety/efficacy in kids vs adults

Ocugen (OCGN) said interim data from phase 2/3 trial of Covaxin, developed by India's Bharat Biotech, was published in a journal and mentioned that the COVID-19 vaccine showed efficacy...

Related Keywords

Mexico ,United States ,Harare ,Mashonaland East ,Zimbabwe ,India ,American ,Bharat ,Tafadzwa Ufumeli Getty ,Krishna Ella , ,Covaxin Vaccine Administered In Harare ,Getty Images ,Bharat Biotech ,Lancet Infectious Diseases ,Bharat Biotech Chairman ,Managing Director Krishna ,North American ,